Oui, l'exposition à des produits chimiques et à des radiations peut augmenter le risque d'anomalies de MCM2.
Exposition environnementaleProduits chimiques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Composant-2 du complexe de maintenance des minichromosomes : Questions médicales les plus fréquentes",
"headline": "Composant-2 du complexe de maintenance des minichromosomes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Composant-2 du complexe de maintenance des minichromosomes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-14",
"dateModified": "2026-04-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Composant-2 du complexe de maintenance des minichromosomes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines de maintenance des minichromosomes",
"url": "https://questionsmedicales.fr/mesh/D064110",
"about": {
"@type": "MedicalCondition",
"name": "Protéines de maintenance des minichromosomes",
"code": {
"@type": "MedicalCode",
"code": "D064110",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.664.235.750"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Composant-2 du complexe de maintenance des minichromosomes",
"alternateName": "Minichromosome Maintenance Complex Component 2",
"code": {
"@type": "MedicalCode",
"code": "D064111",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Qing Yang",
"url": "https://questionsmedicales.fr/author/Qing%20Yang",
"affiliation": {
"@type": "Organization",
"name": "Department of Hepatic Surgery and Liver transplantation Center of the Third Affiliated Hospital, Organ Transplantation Institute, Sun Yat-sen University, Organ Transplantation Research Center of Guangdong Province, 600# Tianhe Road, Guangzhou, 510630, China."
}
},
{
"@type": "Person",
"name": "Binhui Xie",
"url": "https://questionsmedicales.fr/author/Binhui%20Xie",
"affiliation": {
"@type": "Organization",
"name": "Department of Hepatobiliary Surgery, The First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, China."
}
},
{
"@type": "Person",
"name": "Hui Tang",
"url": "https://questionsmedicales.fr/author/Hui%20Tang",
"affiliation": {
"@type": "Organization",
"name": "Department of Hepatic Surgery and Liver transplantation Center of the Third Affiliated Hospital, Organ Transplantation Institute, Sun Yat-sen University, Organ Transplantation Research Center of Guangdong Province, 600# Tianhe Road, Guangzhou, 510630, China."
}
},
{
"@type": "Person",
"name": "Wei Meng",
"url": "https://questionsmedicales.fr/author/Wei%20Meng",
"affiliation": {
"@type": "Organization",
"name": "Department of Hepatic Surgery and Liver transplantation Center of the Third Affiliated Hospital, Organ Transplantation Institute, Sun Yat-sen University, Organ Transplantation Research Center of Guangdong Province, 600# Tianhe Road, Guangzhou, 510630, China."
}
},
{
"@type": "Person",
"name": "Changchang Jia",
"url": "https://questionsmedicales.fr/author/Changchang%20Jia",
"affiliation": {
"@type": "Organization",
"name": "Cell-gene Therapy Translational Medicine Research Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Perivascular invasion of primary human glioblastoma cells in organotypic human brain slices: human cells migrating in human brain.",
"datePublished": "2023-07-25",
"url": "https://questionsmedicales.fr/article/37490233",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11060-023-04349-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Human",
"datePublished": "2024-05-29",
"url": "https://questionsmedicales.fr/article/38807524",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1098/rsif.2024.0074"
}
},
{
"@type": "ScholarlyArticle",
"name": "On human-in-the-loop optimization of human-robot interaction.",
"datePublished": "2024-09-25",
"url": "https://questionsmedicales.fr/article/39322732",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41586-024-07697-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development of a thermodynamics of human cognition and human culture.",
"datePublished": "2023-08-14",
"url": "https://questionsmedicales.fr/article/37573880",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1098/rsta.2022.0378"
}
},
{
"@type": "ScholarlyArticle",
"name": "Industry 5 and the Human in Human-Centric Manufacturing.",
"datePublished": "2023-07-14",
"url": "https://questionsmedicales.fr/article/37514710",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/s23146416"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Nucléoprotéines",
"item": "https://questionsmedicales.fr/mesh/D009698"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines chromosomiques nonhistones",
"item": "https://questionsmedicales.fr/mesh/D002868"
},
{
"@type": "ListItem",
"position": 6,
"name": "Protéines de maintenance des minichromosomes",
"item": "https://questionsmedicales.fr/mesh/D064110"
},
{
"@type": "ListItem",
"position": 7,
"name": "Composant-2 du complexe de maintenance des minichromosomes",
"item": "https://questionsmedicales.fr/mesh/D064111"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Composant-2 du complexe de maintenance des minichromosomes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Composant-2 du complexe de maintenance des minichromosomes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Composant-2 du complexe de maintenance des minichromosomes",
"description": "Comment diagnostiquer une anomalie de MCM2 ?\nQuels tests sont utilisés pour MCM2 ?\nY a-t-il des marqueurs spécifiques pour MCM2 ?\nMCM2 est-il lié à des cancers spécifiques ?\nComment évaluer l'expression de MCM2 ?",
"url": "https://questionsmedicales.fr/mesh/D064111?mesh_terms=Humans#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Composant-2 du complexe de maintenance des minichromosomes",
"description": "Quels symptômes sont liés à des anomalies de MCM2 ?\nMCM2 affecte-t-il le cycle cellulaire ?\nDes symptômes précoces de cancer liés à MCM2 ?\nMCM2 est-il associé à des symptômes neurologiques ?\nLes anomalies de MCM2 causent-elles des symptômes spécifiques ?",
"url": "https://questionsmedicales.fr/mesh/D064111?mesh_terms=Humans#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Composant-2 du complexe de maintenance des minichromosomes",
"description": "Peut-on prévenir les anomalies de MCM2 ?\nDes dépistages recommandés pour MCM2 ?\nL'alimentation influence-t-elle MCM2 ?\nLe tabagisme affecte-t-il MCM2 ?\nDes conseils pour réduire les risques liés à MCM2 ?",
"url": "https://questionsmedicales.fr/mesh/D064111?mesh_terms=Humans#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Composant-2 du complexe de maintenance des minichromosomes",
"description": "Quels traitements ciblent MCM2 ?\nMCM2 influence-t-il la chimiothérapie ?\nY a-t-il des essais cliniques sur MCM2 ?\nComment MCM2 est-il ciblé dans le traitement du cancer ?\nDes traitements préventifs pour les anomalies de MCM2 ?",
"url": "https://questionsmedicales.fr/mesh/D064111?mesh_terms=Humans#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Composant-2 du complexe de maintenance des minichromosomes",
"description": "Quelles complications peuvent survenir avec MCM2 ?\nMCM2 est-il lié à des complications neurologiques ?\nComment gérer les complications liées à MCM2 ?\nLes complications de MCM2 affectent-elles la qualité de vie ?\nY a-t-il des complications spécifiques aux traitements de MCM2 ?",
"url": "https://questionsmedicales.fr/mesh/D064111?mesh_terms=Humans#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Composant-2 du complexe de maintenance des minichromosomes",
"description": "Quels sont les facteurs de risque pour MCM2 ?\nL'âge influence-t-il le risque lié à MCM2 ?\nLe mode de vie affecte-t-il MCM2 ?\nY a-t-il des prédispositions génétiques pour MCM2 ?\nL'exposition environnementale influence-t-elle MCM2 ?",
"url": "https://questionsmedicales.fr/mesh/D064111?mesh_terms=Humans#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie de MCM2 ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques et des analyses de protéines peuvent identifier des anomalies de MCM2."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour MCM2 ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests d'immunoblot et de PCR sont couramment utilisés pour évaluer MCM2."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs spécifiques pour MCM2 ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux élevés de MCM2 dans les cellules peuvent indiquer une prolifération cellulaire accrue."
}
},
{
"@type": "Question",
"name": "MCM2 est-il lié à des cancers spécifiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, MCM2 est souvent associé à des cancers comme le cancer du sein et colorectal."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'expression de MCM2 ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'expression de MCM2 peut être évaluée par des techniques de biologie moléculaire."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à des anomalies de MCM2 ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anomalies de MCM2 peuvent entraîner des troubles de la croissance cellulaire et des cancers."
}
},
{
"@type": "Question",
"name": "MCM2 affecte-t-il le cycle cellulaire ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, MCM2 joue un rôle crucial dans la régulation du cycle cellulaire et la réplication de l'ADN."
}
},
{
"@type": "Question",
"name": "Des symptômes précoces de cancer liés à MCM2 ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fatigue, la perte de poids et des douleurs inexpliquées peuvent survenir."
}
},
{
"@type": "Question",
"name": "MCM2 est-il associé à des symptômes neurologiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un lien entre MCM2 et certains troubles neurologiques, mais ce n'est pas direct."
}
},
{
"@type": "Question",
"name": "Les anomalies de MCM2 causent-elles des symptômes spécifiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anomalies de MCM2 peuvent entraîner des symptômes variés selon le type de cancer associé."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les anomalies de MCM2 ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode spécifique pour prévenir les anomalies de MCM2, mais un mode de vie sain aide."
}
},
{
"@type": "Question",
"name": "Des dépistages recommandés pour MCM2 ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des dépistages réguliers pour les cancers associés à MCM2 sont recommandés, surtout en cas d'antécédents familiaux."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle MCM2 ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut contribuer à la santé cellulaire, mais son impact direct sur MCM2 n'est pas prouvé."
}
},
{
"@type": "Question",
"name": "Le tabagisme affecte-t-il MCM2 ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme est un facteur de risque pour plusieurs cancers, potentiellement liés à MCM2."
}
},
{
"@type": "Question",
"name": "Des conseils pour réduire les risques liés à MCM2 ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un poids santé, éviter le tabac et faire des dépistages réguliers sont conseillés."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent MCM2 ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies ciblées et des inhibiteurs de MCM2 sont en développement pour traiter certains cancers."
}
},
{
"@type": "Question",
"name": "MCM2 influence-t-il la chimiothérapie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'expression de MCM2 peut affecter la sensibilité des cellules tumorales à la chimiothérapie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des essais cliniques sur MCM2 ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, plusieurs essais cliniques évaluent des traitements ciblant MCM2 pour divers cancers."
}
},
{
"@type": "Question",
"name": "Comment MCM2 est-il ciblé dans le traitement du cancer ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "MCM2 est ciblé par des médicaments qui inhibent sa fonction, réduisant ainsi la prolifération tumorale."
}
},
{
"@type": "Question",
"name": "Des traitements préventifs pour les anomalies de MCM2 ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de traitements préventifs spécifiques pour les anomalies de MCM2."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec MCM2 ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des cancers avancés et des métastases en raison d'anomalies de MCM2."
}
},
{
"@type": "Question",
"name": "MCM2 est-il lié à des complications neurologiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recherches explorent le lien entre MCM2 et certaines complications neurologiques, mais ce n'est pas établi."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées à MCM2 ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite un suivi médical régulier et des traitements adaptés."
}
},
{
"@type": "Question",
"name": "Les complications de MCM2 affectent-elles la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications liées à MCM2 peuvent significativement affecter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications spécifiques aux traitements de MCM2 ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements ciblant MCM2 peuvent entraîner des effets secondaires, comme des nausées ou de la fatigue."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour MCM2 ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux de cancer et l'exposition à des agents cancérigènes sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque lié à MCM2 ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de développer des anomalies de MCM2 augmente avec l'âge."
}
},
{
"@type": "Question",
"name": "Le mode de vie affecte-t-il MCM2 ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie malsain, comme le tabagisme et une mauvaise alimentation, augmente le risque."
}
},
{
"@type": "Question",
"name": "Y a-t-il des prédispositions génétiques pour MCM2 ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines mutations génétiques peuvent prédisposer les individus à des anomalies de MCM2."
}
},
{
"@type": "Question",
"name": "L'exposition environnementale influence-t-elle MCM2 ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des produits chimiques et à des radiations peut augmenter le risque d'anomalies de MCM2."
}
}
]
}
]
}
Department of Hepatic Surgery and Liver transplantation Center of the Third Affiliated Hospital, Organ Transplantation Institute, Sun Yat-sen University, Organ Transplantation Research Center of Guangdong Province, 600# Tianhe Road, Guangzhou, 510630, China.
Publications dans "Composant-2 du complexe de maintenance des minichromosomes" :
Department of Hepatic Surgery and Liver transplantation Center of the Third Affiliated Hospital, Organ Transplantation Institute, Sun Yat-sen University, Organ Transplantation Research Center of Guangdong Province, 600# Tianhe Road, Guangzhou, 510630, China.
Publications dans "Composant-2 du complexe de maintenance des minichromosomes" :
Department of Hepatic Surgery and Liver transplantation Center of the Third Affiliated Hospital, Organ Transplantation Institute, Sun Yat-sen University, Organ Transplantation Research Center of Guangdong Province, 600# Tianhe Road, Guangzhou, 510630, China.
Publications dans "Composant-2 du complexe de maintenance des minichromosomes" :
Department of Hepatic Surgery and Liver transplantation Center of the Third Affiliated Hospital, Organ Transplantation Institute, Sun Yat-sen University, Organ Transplantation Research Center of Guangdong Province, 600# Tianhe Road, Guangzhou, 510630, China.
Publications dans "Composant-2 du complexe de maintenance des minichromosomes" :
Department of Hepatic Surgery and Liver transplantation Center of the Third Affiliated Hospital, Organ Transplantation Institute, Sun Yat-sen University, Organ Transplantation Research Center of Guangdong Province, 600# Tianhe Road, Guangzhou, 510630, China. zhjianw2@mail.sysu.edu.cn.
Publications dans "Composant-2 du complexe de maintenance des minichromosomes" :
Department of Medical Oncology of the Eastern Hospital, The First Affiliated Hospital of Sun Yat-sen University, Zhongshan Er Road, Guangzhou, 510080, China. drliheping@163.com.
Publications dans "Composant-2 du complexe de maintenance des minichromosomes" :
Department of Hepatic Surgery and Liver transplantation Center of the Third Affiliated Hospital, Organ Transplantation Institute, Sun Yat-sen University, Organ Transplantation Research Center of Guangdong Province, 600# Tianhe Road, Guangzhou, 510630, China. fubinsh@mail.sysu.edu.cn.
Publications dans "Composant-2 du complexe de maintenance des minichromosomes" :
Glioblastoma (GBM) is an aggressive primary brain cancer. Lack of effective therapy is related to its highly invasive nature. GBM invasion has been studied with reductionist systems that do not fully ...
Non-tumor brain samples were obtained from patients undergoing surgery (n = 7). Organotypic brain slices were prepared, and green fluorescent protein (GFP)-labeled primary human GBM IDH-wild type cell...
After placement, cells migrated towards blood vessels; initially migrating with limited directionality, sending processes in different directions, and increasing their speed upon contact with the vess...
Human organotypic models can accurately study cell migration ex vivo. GBM IDH-wild type cells migrate toward the perivascular space in blood vessels and their migratory parameters change once they con...
The interaction among joints of the midtarsal complex and subtalar joint is important for locomotor function; however, its complexity poses substantial challenges in quantifying the joints' motions. W...
From industrial exoskeletons to implantable medical devices, robots that interact closely with people are poised to improve every aspect of our lives. Yet designing these systems is very challenging; ...
Inspired by foundational studies in classical and quantum physics, and by information retrieval studies in quantum information theory, we prove that the notions of 'energy' and 'entropy' can be consis...
Industry 4 (I4) was a revolutionary new stage for technological progress in manufacturing which promised a new level of interconnectedness between a diverse range of technologies. Sensors, as a point ...
As the global population rapidly ages with longer life expectancy and declining birth rates, the need for healthcare services and caregivers for older adults is increasing. Current research envisions ...
Bowers et al. express skepticism about deep neural networks (DNNs) as models of human vision due to DNNs' failures to account for results from psychological research. We argue that to fairly assess DN...
Humans can easily perform various types of hugs in human contact and affection experience. With the prevalence of robots in social applications, they would be expected to possess the capability of hug...
All human groups are equally human, but are they automatically represented as such? Harnessing data from 61,377 participants across 13 experiments (six primary and seven supplemental), a sharp dissoci...
Allogeneic stem cell transplantation (alloSCT) can be curative for hemato-oncology patients due to effective graft-versus-tumor immunity. However, relapse remains the major cause of treatment failure,...